E. Cummings

Most-cited papers

1. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

   P. Bowman, Åsta Sulen, F. Barbetti, J. Beltrand +130 more

   2018The Lancet Diabetes and Endocrinology130 citations Open access

   Semantic Scholar

   Save

2. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program

   C. Child, A. Zimmermann, G. Chrousos, E. Cummings +15 more

   2018Journal of Clinical Endocrinology and Metabolism65 citations Open access

   Semantic Scholar

   Save

3. Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).

   James L McKinney, Henian Cao, John F. Robinson, D. Metzger +6 more

   2004Clinical and investigative medicine. Medecine clinique et experimentale24 citations

   Semantic Scholar

   Save

4. Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the pediatric heart transplant society (PHTS) registry.

   J. Godown, R. Cantor, D. Koehl, E. Cummings +22 more

   2021The Journal of Heart and Lung Transplantation20 citations

   Semantic Scholar

   Save

5. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY)

   Henian Cao, S. Shorey, John F. Robinson, D. Metzger +3 more

   2002Human Mutation20 citations Open access

   Semantic Scholar

   Save

6. Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study.

   C. Deal, S. Kirsch, J. Chanoine, S. Lawrence +5 more

   2018CMAJ Open13 citations Open access

   Semantic Scholar

   Save